Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06832267

Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL

This study aims to observe and explore the efficacy and safety of Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) regimen as first-line therapy for primary…

China44 participantsStarted 2025-02-14

Treatment: Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT)

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07147751

Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach

PCNS-DLBCL is a rare extranodal non-Hodgkin lymphoma that primarily affects the brain, spine, or vitreoretinal space. The prognosis for PCNS-DLBCL is significan…

Italy, Switzerland100 participantsStarted 2026-04

CompletedNot Applicable

NCT07007611

The Role of Surgical Resection AND Stereotactic Radiosurgery in Primary Central Nervous System -Diffuse Large B Cell Lym…

The objective of this observational study is to understand the long-term impact of surgery and gamma knife treatment on primary central diffuse large B-cell lym…

Location not specified76 participantsStarted 2006-12-01